<DOC>
	<DOCNO>NCT02183142</DOCNO>
	<brief_summary>The objective study compare pharmacokinetic parameter 7.5 mg Mobic tablet manufacture china comparison 7.5 mg tablet manufacture Germany</brief_summary>
	<brief_title>Study Relative Bioavailability Mobic Manufactured China Comparison With Mobic Manufactured Germany Chinese Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Chinese healthy male volunteer determine result screen Written informed consent accordance Good Clinical Practice ( GCP ) Age &gt; = 18 &lt; = 40 year Broca &gt; 20 % &lt; + 20 % Any finding medical examination ( blood pressure , pulse rate Electrocardiogram ( ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder Chronic relevant acute infection Hypersensitivity Mobic and/or nonsteroidal antiinflammatory drug Intake drug within 1 month randomization Participation another trial investigational drug within last 2 month trial Smokers ( &gt; = 10 cigarette &gt; = 3 cigar &gt; = 3 pipes/day ) inability refrain smoke study day Alcohol drug abuse Blood donation within last 1 month Excessive physical activity within last 5 day History hemorrhagic diatheses History gastrointestinal ulcer , perforation bleed History bronchial asthma</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>